Product Information
HYDROMORPHONE 8 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.5683 per EA under NDC 13107010901. Its NADAC has been published 515 times since Oct 12, 2016.
FDA first approved this application on May 13, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107010901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205814FDA Approved
5/13/2016
TE Code
AB
On Market Since
5/17/2016
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE 8 MG TABLET has been published 515 times since Oct 12, 2016, and over the history we have for it it has risen 58.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5683 per EA |
|---|---|
| All-time high | $0.5683 (Aug 19, 2026) |
| All-time low | $0.2311 (Nov 20, 2019) |
| 52-week high | $0.5683 |
| 52-week low | $0.5470 |
| Median price | $0.2891 |
| Average price | $0.3385 |
| Largest weekly change | +25.0% (Aug 23, 2023) |
| Weeks tracked | 515 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the HYDROMORPHONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROMORPHONE 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 8 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.5683 per EA (NDC 13107010901), effective Aug 19, 2026.
How has the price of HYDROMORPHONE 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE 8 MG TABLET has risen 58.3%. It has been tracked across 515 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 8 MG TABLET?
Since Oct 12, 2016, the NADAC for HYDROMORPHONE 8 MG TABLET has ranged from a low of $0.2311 (Nov 20, 2019) to a high of $0.5683 (Aug 19, 2026), with a median of $0.2891 per EA.
Are there cheaper alternatives to HYDROMORPHONE 8 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of HYDROMORPHONE 8 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROMORPHONE 8 MG TABLET?
HYDROMORPHONE 8 MG TABLET (NDC 13107010901) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.